技術指標
指標
數值
方向
MACD(12,26,9)
-0.294
中性
RSI(14)
49.884
中性
STOCH(KDJ)(9,3,3)
50.938
中性
ATR(14)
1.358
高波動
CCI(14)
-159.499
賣出
Williams %R
55.844
賣出
TRIX(12,20)
0.080
賣出
StochRSI(14)
0.000
超賣
搜尋
Indivior PLC
INDV添加自選
40.010USD
-0.210-0.52%
收盤 07-31 16:00（美東）報價延遲15分鐘
4.88B總市值
23.82本益比TTM
關鍵數據
39.960今開
40.305最高
1.35M成交量
23.82本益比TTM
9.89本益比動
--股利TTM
1.11%換手率
40.220昨收
38.630最低
40.91M成交額
2440.61本益比靜
-33.90市淨率
0.00%股息率 TTM
16.69%ROA
41.00052週最高
0.94量比
2.00M淨利潤
122.00M總股本
1.6800每股盈餘TTM
1.18Beta
-307.32%ROE
12.04052週最低
4.16%振幅
87.38%毛利率
4.88B總市值
0.29回報/風險
1.95%風險率
TradingKey Indivior PLC股票評分
單位: USD 更新時間: 2026-07-31操作建議
Indivior PLC當前公司基本面數據相對穩定，增長潛力很大。當前估值合理，在藥品行業排名46/155位。機構持股佔比非常高，近一月多位分析師給出公司評級為買入。最高目標價為49.17。中期看，股價處於平穩狀態。近一個月，市場表現一般，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
Indivior PLC評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看好
Indivior PLC亮點
亮點風險
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
估值合理
公司最新PE估值23.82，處於3年歷史合理位
機構減倉
最新機構持股123.98M股，環比減少7.92%
分析師目標
基於
6
分析師
買入
評級
49.167
目標均價
+22.61%
漲幅空間
Indivior PLC新聞
即將為您帶來更多新聞，敬請期待。 。 。
收益預測
分析師評級
基於
6
分析師
買入
評級
49.167
目標均價
+22.61%
漲幅空間
強力買入
買入
持有
賣出
強力賣出
同行比較
160
總數
6
中位數
9
平均值
公司名稱
評級分佈
分析師數
Indivior PLC
INDV
6
Biogen Inc
BIIB
37
Amgen Inc
AMGN
37
Eli Lilly and Co
LLY
34
輝瑞
PFE
32
艾伯維
ABBV
32
1
2
3
...
32
技術指標
移動平均線
指標
數值
方向
MA5
40.270
賣出
MA10
40.240
賣出
MA20
40.421
賣出
MA50
39.117
買入
MA100
36.250
買入
MA200
34.470
買入
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
Indivior PLC簡介
Indivior PLC is a global pharmaceutical company engaged in developing medicines to treat substance-use disorders (SUD). The Company provides treatment for addiction, including SUBLOCADE (buprenorphine extended-release) injection for subcutaneous use, a long-acting injectable (LAI) for opioid use disorder and OPVEE (Nalmefene) nasal spray for opioid overdose recovery. Its core products include SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, OPVEE (nalmefene), and SUBLOCADE. SUBOXONE Film is a buprenorphine and naloxone sublingual film. SUBOXONE Tablet is a buprenorphine and naloxone sublingual tablet. SUBUTEX Tablet is a buprenorphine sublingual tablet. SUBOXONE Film, SUBOXONE Tablet, SUBUTEX Tablet, and SUBLOCADE are treatments for opioid use disorder (OUD). In addition to its commercially available products, its product pipeline includes two drug candidates for the treatment of OUD. The Company sells its products in the United States and in other selected areas of the world.
公司代碼INDV
公司Indivior PLC
CEOCiaffoni (Joseph J)
網址https://www.indivior.com/en
公司股東
相關品種
-0.53%
+0.27%
-0.92%
-2.51%
+0.32%
-1.45%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
+1.30%
-0.90%
-2.15%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
Indivior PLC(INDV)的當前股價是多少？
Indivior PLC(INDV)的當前股價是 40.01。
Indivior PLC 的股票代碼是什麼？
Indivior PLC的股票代碼是INDV。
Indivior PLC股票的52週最高點是多少？
Indivior PLC股票的52週最高點是41.00。
Indivior PLC股票的52週最低點是多少？
Indivior PLC股票的52週最低點是12.04。
Indivior PLC的市值是多少？
Indivior PLC的市值是4.88B。
現在Indivior PLC(INDV)的股票是買入、持有還是賣出？
根據分析師評級，Indivior PLC(INDV)的總體評級為買入，目標價格為49.17。
Indivior PLC(INDV)股票的每股收益（EPS TTM）是多少
Indivior PLC(INDV)股票的每股收益（EPS TTM）是1.68。